Terms: = Gastric cancer AND PRF1, P14222, PFP, P1, MGC65093, HPLH2, FLH2, ENSG00000180644, 5551 AND Prognosis
41 results:
1. The Significance of Staging Laparoscopy in Detection of Radiologically Occult Peritoneal Carcinomatosis in gastric cancer With gastric Outlet Obstruction: Consideration of The Optimal Treatment Approach.
Komatsu M; Kinoshita T; Akimoto E; Yoshida M; Terajima D; Nagata H; Habu T; Okayama T; Takabe Y; Harada J; Yamaguchi M; Yura M
Anticancer Res; 2022 Nov; 42(11):5571-5578. PubMed ID: 36288848
[TBL] [Abstract] [Full Text] [Related]
2. Profiling the Tumor-Infiltrating Lymphocytes in gastric cancer Reveals Its Implication in the prognosis.
Yu W; Wang S; Rong Q; Ajayi OE; Hu K; Wu Q
Genes (Basel); 2022 Jun; 13(6):. PubMed ID: 35741779
[TBL] [Abstract] [Full Text] [Related]
3. Cytolytic activity score as a biomarker for antitumor immunity and clinical outcome in patients with gastric cancer.
Hu Q; Nonaka K; Wakiyama H; Miyashita Y; Fujimoto Y; Jogo T; Hokonohara K; Nakanishi R; Hisamatsu Y; Ando K; Kimura Y; Masuda T; Oki E; Mimori K; Oda Y; Mori M
Cancer Med; 2021 May; 10(9):3129-3138. PubMed ID: 33769705
[TBL] [Abstract] [Full Text] [Related]
4. Prospective study to validate the clinical utility of DNA diagnosis of peritoneal fluid cytology test in gastric cancer.
Harada H; Soeno T; Nishizawa N; Washio M; Sakuraya M; Ushiku H; Niihara M; Hosoda K; Kumamoto Y; Naitoh T; Sangai T; Hiki N; Yamashita K
Cancer Sci; 2021 Apr; 112(4):1644-1654. PubMed ID: 33576114
[TBL] [Abstract] [Full Text] [Related]
5. Intratumoral CD103
Gu Y; Chen Y; Jin K; Cao Y; Liu X; Lv K; He X; Lin C; Liu H; Li H; He H; Qin J; Li R; Zhang H; Zhang W
Oncoimmunology; 2020 Nov; 9(1):1844402. PubMed ID: 33312758
[TBL] [Abstract] [Full Text] [Related]
6. Epstein-Barr virus-encoded miR-BART11 promotes tumor-associated macrophage-induced epithelial-mesenchymal transition via targeting FOXP1 in gastric cancer.
Song Y; Li Q; Liao S; Zhong K; Jin Y; Zeng T
Virology; 2020 Sep; 548():6-16. PubMed ID: 32530809
[TBL] [Abstract] [Full Text] [Related]
7. [Application of laparoscopic exploration combined with abdominal exfoliative cytology in the diagnosis and treatment of locally advanced gastric cancer].
Ding PA; Liu Y; Guo HH; Yang PG; Tian Y; Fan LQ; Tan BB; Li Y; Zhao Q
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Feb; 23(2):170-176. PubMed ID: 32074798
[No Abstract] [Full Text] [Related]
8. [A Case of cancerous Meningitis in Juvenile Onset gastric cancer].
Kamada Y; Kamiya H; Kambe K; Iguchi M; Nagata T; Fukuda K; Iwata G; Yamaoka N; Tsukamoto K
Gan To Kagaku Ryoho; 2018 Dec; 45(13):1958-1960. PubMed ID: 30692410
[TBL] [Abstract] [Full Text] [Related]
9. Intratumoral IL17-producing cells infiltration correlate with antitumor immune contexture and improved response to adjuvant chemotherapy in gastric cancer.
Wang JT; Li H; Zhang H; Chen YF; Cao YF; Li RC; Lin C; Wei YC; Xiang XN; Fang HJ; Zhang HY; Gu Y; Liu X; Zhou RJ; Liu H; He HY; Zhang WJ; Shen ZB; Qin J; Xu JJ
Ann Oncol; 2019 Feb; 30(2):266-273. PubMed ID: 30445581
[TBL] [Abstract] [Full Text] [Related]
10. Conversion Surgery for gastric cancer with Peritoneal Metastasis Based on the Diagnosis of Second-Look Staging Laparoscopy.
Nakamura M; Ojima T; Nakamori M; Katsuda M; Tsuji T; Hayata K; Kato T; Yamaue H
J Gastrointest Surg; 2019 Sep; 23(9):1758-1766. PubMed ID: 30264385
[TBL] [Abstract] [Full Text] [Related]
11. Transcriptional analysis of immune genes in Epstein-Barr virus-associated gastric cancer and association with clinical outcomes.
Sundar R; Qamra A; Tan ALK; Zhang S; Ng CCY; Teh BT; Lee J; Kim KM; Tan P
Gastric Cancer; 2018 Nov; 21(6):1064-1070. PubMed ID: 29915957
[TBL] [Abstract] [Full Text] [Related]
12. Addition of peritonectomy to gastrectomy can predict good prognosis of gastric adenocarcinoma patients with intraoperatively proven single P1/P2 carcinomatosis.
Li S; Lan X; Gao H; Wang W; Chen L; Song S; Xue Y
Tumour Biol; 2017 Jun; 39(6):1010428317697567. PubMed ID: 28618957
[TBL] [Abstract] [Full Text] [Related]
13. Surgery after intraperitoneal and systemic chemotherapy for gastric cancer with peritoneal metastasis or positive peritoneal cytology findings.
Ishigami H; Yamaguchi H; Yamashita H; Asakage M; Kitayama J
Gastric Cancer; 2017 Mar; 20(Suppl 1):128-134. PubMed ID: 28028665
[TBL] [Abstract] [Full Text] [Related]
14. [Examination of outcomes after conversion surgery for Stage IVgastric cancer in our hospital].
Hagino S; Kurata T; Makita N; Tsuneda A; Iwata K; Kiriyama M
Gan To Kagaku Ryoho; 2014 Nov; 41(12):2293-5. PubMed ID: 25731500
[TBL] [Abstract] [Full Text] [Related]
15. Who will benefit from noncurative resection in patients with gastric cancer with single peritoneal metastasis?
Xia X; Li C; Yan M; Liu B; Yao X; Zhu Z
Am Surg; 2014 Feb; 80(2):124-30. PubMed ID: 24480211
[TBL] [Abstract] [Full Text] [Related]
16. [Therapeutic strategy for gastric cancer with positive peritoneal lavage cytology without peritoneal dissemination].
Iwasaki Y; Ohashi M; Iwanaga T; Oohinata R; Yuu K; Takahashi K; Yamaguchi T; Matsumoto H; Nakano D
Gan To Kagaku Ryoho; 2012 Dec; 39(13):2451-4. PubMed ID: 23235163
[TBL] [Abstract] [Full Text] [Related]
17. Prognostic value of expression of Kit67, p53, TopoIIa and GSTP1 for curatively resected advanced gastric cancer patients receiving adjuvant paclitaxel plus capecitabine chemotherapy.
Zha Y; Cun Y; Zhang Q; Li Y; Tan J
Hepatogastroenterology; 2012; 59(117):1327-32. PubMed ID: 22534478
[TBL] [Abstract] [Full Text] [Related]
18. Prognostic significance of peritoneal washing cytology in patients with gastric cancer.
Lee SD; Ryu KW; Eom BW; Lee JH; Kook MC; Kim YW
Br J Surg; 2012 Mar; 99(3):397-403. PubMed ID: 22101572
[TBL] [Abstract] [Full Text] [Related]
19. Borrmann's macroscopic criteria and p-Smad2 expression are useful predictive prognostic markers for cytology-positive gastric cancer patients without overt peritoneal metastasis.
Noda S; Yashiro M; Toyokawa T; Morimoto J; Shinto O; Muguruma K; Sawada T; Hirakawa K
Ann Surg Oncol; 2011 Dec; 18(13):3718-25. PubMed ID: 21573834
[TBL] [Abstract] [Full Text] [Related]
20. Genetic polymorphism of GSTP1: prediction of clinical outcome to oxaliplatin/5-FU-based chemotherapy in advanced gastric cancer.
Li QF; Yao RY; Liu KW; Lv HY; Jiang T; Liang J
J Korean Med Sci; 2010 Jun; 25(6):846-52. PubMed ID: 20514304
[TBL] [Abstract] [Full Text] [Related]
[Next]
